tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Julie Mead, 1 are a SELL (33.33%), 2 are a HOLD (66.67%).
Analyst Julie Mead, currently employed at HSBC,
Julie Mead’s has documented 5 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 15-Oct-2021.
Analyst best performing recommendations are on AZN (ASTRAZENECA PLC ADR).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$87
$19.43 (28.76%)
$78
5 months 23 days ago
(17-Nov-2024)
8/9 (88.89%)
$23.61 (37.25%)
588
Buy
$88
$20.43 (30.24%)
$82
5 months 28 days ago
(12-Nov-2024)
4/5 (80%)
$22.71 (34.78%)
297
Buy
$95
$27.43 (40.59%)
$66
8 months 29 days ago
(12-Aug-2024)
6/7 (85.71%)
$12.48 (15.12%)
382
Buy
$85
$17.43 (25.80%)
$80
11 months 11 days ago
(30-May-2024)
4/4 (100%)
$8.7 (11.40%)
391
Buy
$84
$16.43 (24.32%)
$85
1 years 19 days ago
(22-Apr-2024)
2/12 (16.67%)
$14.3 (20.52%)
163
What Year was the first public recommendation made by Julie Mead?
